GENEURO SA |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.845 EUR | -3.91% |
|
+7.89% | +69.27% |
| 16/05 | GeNeuro SA Announces Last Patient Last Visit in Its Post-Covid Trial and Confirms Top-Line Results by End of June 2024 | CI |
| 20/03 | Geneuro SA Announces Appointments of Board of Directors | CI |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Equities
- GNRO Stock
- Revisions GeNeuro SA
